UK Markets close in 8 hrs 26 mins
  • FTSE 100

    6,963.64
    -63.84 (-0.91%)
     
  • FTSE 250

    23,658.94
    0.00 (0.00%)
     
  • AIM

    1,275.74
    0.00 (0.00%)
     
  • GBP/EUR

    1.1680
    -0.0033 (-0.28%)
     
  • GBP/USD

    1.3688
    -0.0050 (-0.3627%)
     
  • BTC-GBP

    33,410.29
    -1,954.51 (-5.53%)
     
  • CMC Crypto 200

    1,140.76
    -84.77 (-6.92%)
     
  • S&P 500

    4,432.99
    -40.76 (-0.91%)
     
  • DOW

    34,584.88
    -166.42 (-0.48%)
     
  • CRUDE OIL

    71.27
    -0.70 (-0.97%)
     
  • GOLD FUTURES

    1,753.90
    +2.50 (+0.14%)
     
  • NIKKEI 225

    30,500.05
    +176.75 (+0.58%)
     
  • HANG SENG

    24,008.03
    -912.73 (-3.66%)
     
  • DAX

    15,490.17
    -161.63 (-1.03%)
     
  • CAC 40

    6,570.19
    0.00 (0.00%)
     

Global Animal Health Active Pharmaceutical Ingredients Market Report 2021: Growing Research and Development for New Products Presents Opportunities

·4-min read

Dublin, Aug. 23, 2021 (GLOBE NEWSWIRE) -- The "Global Animal Health Active Pharmaceutical Ingredients Market (2021-2026) by Business, Indication, Synthesis, Type, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Animal Health Active Pharmaceutical Ingredients Market is estimated to be USD 16.12 Bn in 2021 and is expected to reach USD 23.63 Bn by 2026, growing at a CAGR of 7.95%.

Market Dynamics

The global animal health active pharmaceutical ingredients market is being driven by increasing animal healthcare infrastructure and facilities, rising focus on animal well-being, an increase in the number of animal healthcare NGOs, increased pet adoption, and unmet medical needs.

In addition, as the economies are growing, more governments and pharmaceutical firms are investing in animal healthcare, and the rising research and development activities and the growing focus on innovations are projected to offer lucrative growth opportunities for the growth of global animal health active pharmaceutical ingredients market.

However, the market's development is being restrained by rising costs and the Government's regulatory prohibitions on the animal pharmaceuticals industry.

Market Segmentation

  • The Global Animal Health Active Pharmaceutical Ingredients Market is segmented further based on Business, Indication, Synthesis, Type, End-User, and Geography.

  • By Business, the market is classified into captive API and merchant API. Amongst the two, the captive API segment is estimated to hold the highest market share during the forecast period.

  • By Indication, the market is classified as anti-infective, antiparasitics, and NSAIDS & anesthetics. Amongst all, the anti-infective segment is estimated to hold the highest market share during the forecast period.

  • By Synthesis, the market is classified as biotech and synthetic. Amongst the two, the biotech segment is estimated to hold the highest market share during the forecast period.

  • By Type, the market is classified as branded and generic. Amongst the two, the branded segment is estimated to hold the highest market share during the forecast period.

  • By End User, the market is classified as pet care hospitals, retail, and specialty pharmacies. Amongst all, the pet care hospitals segment is estimated to hold the highest market share during the forecast period.

  • By Geography, North America is projected to lead the market.

Recent Developments

  • INROADS partners with Zoetis for diversity opportunities in animal health. - 9th February 2021.

  • Olon S.p.A., a world-leading active pharmaceutical ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier, announced Capua BioServices S.p.A., a global provider of CDMO services in the field of microbial fermentation.- 25th January 2019.

Key Topics Covered:

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders

2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.3 Market Size Estimation
2.4 Assumptions of the Study
2.5 Limitations of the Study

3 Executive Summary
3.1 Introduction
3.2 Market Size and Segmentation
3.3 Market Outlook

4 Market Influencers
4.1 Drivers
4.1.1 Increasing Adoption of Pets
4.1.2 Increase in the Number of Animal Healthcare NGOs
4.2 Restraints
4.2.1 Risk Associated with Animal Health APIs
4.2.2 High Investment
4.3 Opportunities
4.3.1 Growing Research and Development for New Products
4.4 Challenges
4.4.1 Limited Awareness Towards Animal Health
4.5 Trends

5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis

6 Global Animal Health Active Pharmaceutical Ingredients Market, By Business
6.1 Introduction
6.2 Captive API
6.3 Merchant API

7 Global Animal Health Active Pharmaceutical Ingredients Market, By Indication
7.1 Introduction
7.2 Anti-infectives
7.3 Antiparasitic
7.4 NSAIDs & Anesthetics

8 Global Animal Health Active Pharmaceutical Ingredients Market, By Synthesis
8.1 Introduction
8.2 Biotech
8.3 Synthetic

9 Global Animal Health Active Pharmaceutical Ingredients Market, By Type
9.1 Introduction
9.2 Branded
9.3 Generic

10 Global Animal Health Active Pharmaceutical Ingredients Market, By End User
10.1 Introduction
10.2 Pet Care Hospitals
10.3 Retail
10.4 Specialty pharmacies

11 Global Animal Health Active Pharmaceutical Ingredients Market, By Geography

12 Competitive Landscape
12.1 Competitive Quadrant
12.2 Market Share Analysis
12.3 Strategic Initiatives
12.3.1 M&A and Investments
12.3.2 Partnerships and Collaborations
12.3.3 Product Developments and Improvements

13 Company Profiles

  • Blanver Farmoquimica E Farmaceutica S.A

  • Changzhou Yabang-Qh Pharmachem Co., Ltd

  • Eli Lilly & Co

  • Excel Industries Ltd

  • Glenmark Pharmaceutical Ltd.

  • Huvepharma

  • Indukern, S.A

  • Lonza Group AG

  • NGL Fine Chem Ltd

  • Ningxia Tairui Pharma CO. Ltd

  • Ofichem BV

  • Omkar Speciality Chemicals Limited

  • Ourofino Saude Animal

  • P&R SpA (Olon SpA)

  • Sanofi Winthrop Industrie (CEPiA)

  • Sequent Scientific Ltd

  • Shaanxi Hanjiang Pharmaceutical Group Co., Ltd

  • Shanghai Pharmtech Co. Ltd

  • Zhejiang Hisun Pharmaceutical Co. Ltd

  • Zoetis Inc.

For more information about this report visit https://www.researchandmarkets.com/r/77ipuh

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting